|
Volumn 19, Issue 3, 2009, Pages 416-424
|
Effect of the inhibition of joint destruction in RA by TNF-blocking agents
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ADALIMUMAB;
IMMUNOGLOBULIN G;
INFLIXIMAB;
MONOCLONAL ANTIBODY;
TNFR FC FUSION PROTEIN;
TNFR-FC FUSION PROTEIN;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR RECEPTOR;
ANIMAL;
CLINICAL TRIAL;
DRUG ANTAGONISM;
HUMAN;
IMMUNOLOGY;
JOINT;
PATHOLOGY;
REVIEW;
RHEUMATOID ARTHRITIS;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ARTHRITIS, RHEUMATOID;
CLINICAL TRIALS AS TOPIC;
HUMANS;
IMMUNOGLOBULIN G;
JOINTS;
RECEPTORS, TUMOR NECROSIS FACTOR;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 66149140243
PISSN: 09175857
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (1)
|
References (16)
|